HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weiyang He Selected Research

eIF-4B

3/2022PP2A promotes apoptosis and facilitates docetaxel sensitivity via the PP2A/p-eIF4B/XIAP signaling pathway in prostate cancer.
9/2013The over-expression of Pim-2 promote the tumorigenesis of prostatic carcinoma through phosphorylating eIF4B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Weiyang He Research Topics

Disease

20Neoplasms (Cancer)
10/2022 - 04/2012
16Urinary Bladder Neoplasms (Bladder Cancer)
10/2022 - 04/2015
5Prostatic Neoplasms (Prostate Cancer)
03/2022 - 01/2014
5Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2018
4Lung Neoplasms (Lung Cancer)
11/2021 - 04/2012
4Carcinogenesis
01/2020 - 09/2013
3Carcinoma (Carcinomatosis)
01/2021 - 09/2013
3Heart Arrest (Cardiac Arrest)
07/2018 - 12/2017
2Starvation
11/2021 - 01/2019
2Neoplasm Metastasis (Metastasis)
01/2021 - 01/2020
2Inflammation (Inflammations)
06/2018 - 01/2014
2Reperfusion Injury
06/2018 - 05/2018
2Ischemia
05/2018 - 01/2014
1Colorectal Neoplasms (Colorectal Cancer)
11/2021
1Breast Neoplasms (Breast Cancer)
11/2021
1Metabolic Diseases (Metabolic Disease)
01/2021
1Stomach Neoplasms (Stomach Cancer)
01/2021
1Wounds and Injuries (Trauma)
11/2019
1Hypoxia (Hypoxemia)
07/2018
1Death (Near-Death Experience)
06/2018
1Flatulence
01/2018
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2018
1Acute Kidney Injury (Acute Renal Failure)
01/2014
1Hyperplasia
01/2013

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
10/2022 - 09/2013
5Long Noncoding RNAIBA
01/2021 - 10/2018
4Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2019
3Messenger RNA (mRNA)IBA
03/2022 - 10/2018
3Cisplatin (Platino)FDA LinkGeneric
11/2021 - 03/2014
3Biological ProductsIBA
01/2020 - 01/2019
3MicroRNAs (MicroRNA)IBA
01/2020 - 10/2018
2Hormones (Hormone)IBA
03/2022 - 05/2017
2eIF-4BIBA
03/2022 - 09/2013
2CateninsIBA
11/2021 - 01/2020
2cyclobutanecarbonylcarnitine (CBCC)IBA
07/2020 - 04/2015
2Cell Adhesion MoleculesIBA
01/2020 - 10/2018
2SolutionsIBA
11/2019 - 01/2014
2Mitogen-Activated Protein KinasesIBA
01/2019 - 04/2012
2Competitive Endogenous RNAIBA
01/2019 - 10/2018
2Beclin-1IBA
07/2018 - 01/2018
2dicarboxydine (DCD)IBA
07/2018 - 06/2018
2GemcitabineFDA Link
07/2018 - 09/2017
1Epidermal Growth Factor (EGF)IBA
10/2022
1Carrier Proteins (Binding Protein)IBA
10/2022
1Docetaxel (Taxotere)FDA Link
03/2022
1Factor X (Stuart Factor)IBA
03/2022
1Glucose (Dextrose)FDA LinkGeneric
11/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Fetuin-BIBA
11/2020
1Cysteine Proteinase InhibitorsIBA
11/2020
1740Y-PIBA
11/2020
1Glycoproteins (Glycoprotein)IBA
11/2020
16- (2- tert- butyl- 5- (6- methylpyridin- 2- yl)- 1H- imidazol- 4- yl)quinoxalineIBA
01/2020
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
01/2020
1elemeneIBA
01/2020
1VimentinIBA
01/2020
1Transforming Growth Factor-beta Type I ReceptorIBA
01/2020
1ChitinIBA
11/2019
1CollagenIBA
11/2019
1Urea (Carbamide)FDA LinkGeneric
11/2019
1Collagen Type I (Type I Collagen)IBA
11/2019
1Small Interfering RNA (siRNA)IBA
01/2019
1Dual Specificity Phosphatase 2IBA
01/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019
14- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA
01/2019
1Cytokine Receptors (Cytokine Receptor)IBA
10/2018
1CytokinesIBA
10/2018
1InflammasomesIBA
06/2018
1Sirolimus (Rapamycin)FDA Link
05/2018
1EverolimusFDA Link
01/2018
1TOR Serine-Threonine KinasesIBA
01/2018
1HMGB1 Protein (HMG1)IBA
09/2017
1Celecoxib (Celebrex)FDA Link
05/2017
1JNK Mitogen-Activated Protein KinasesIBA
05/2017
1Pharmaceutical PreparationsIBA
11/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2016
1AlginatesIBA
11/2016
13- (3- hydroxy- 4- methoxyphenyl)- 1- (3,4,5- trimethoxyphenyl)prop- 2- en- 1- oneIBA
05/2016
1TNF-Related Apoptosis-Inducing LigandIBA
05/2016
1Chalcone (Benzalacetophenone)IBA
05/2016
1Tripartite Motif ProteinsIBA
07/2015
1celastrolIBA
01/2014
1AndrogensIBA
01/2014
1Androgen Receptors (Androgen Receptor)IBA
01/2014
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
12/2012
1Phosphotransferases (Kinase)IBA
04/2012
1Superoxides (Superoxide)IBA
04/2012
1LuteolinIBA
04/2012

Therapy/Procedure

6Drug Therapy (Chemotherapy)
11/2021 - 03/2014
5Therapeutics
01/2020 - 04/2012
3Cystectomy
07/2020 - 01/2018
3Warm Ischemia
07/2018 - 12/2017
2Liver Transplantation
07/2018 - 06/2018
2Urinary Diversion (Ileal Conduit)
01/2018 - 01/2018
1Castration
03/2022
1Neoadjuvant Therapy
01/2021
1Length of Stay
01/2018
1Enhanced Recovery After Surgery
01/2018
1Transurethral Resection of Prostate (TURP)
01/2013